Patents by Inventor Hyo Jin Kang

Hyo Jin Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190240270
    Abstract: Provided are a functional food or pharmaceutical composition or a method for preventing, alleviating or treating hyperphosphatemia and chronic kidney disease and treating chronic kidney disease using the composition comprising Lactobacillus sp. KCCM 11826P having excellent phosphorus-absorbing ability.
    Type: Application
    Filed: January 26, 2017
    Publication date: August 8, 2019
    Applicants: KOREA FOOD RESEARCH INSTITUTE, Catholic Kwandong University Industry Foundation
    Inventors: Hyo Jin KIM, Hae Won JANG, Young-Wook CHIN, Woo Kyung KANG, Sung Jin MOON
  • Patent number: 10352580
    Abstract: An air conditioner includes a housing having a suction port and a discharge port, a main fan configured to draw air into the housing through the suction port and discharge air from the housing through the discharge port, an auxiliary fan configured to draw, into the housing, air discharged by the main fan and a controller configured to control a rotational speed of the auxiliary fan to change a direction in which air is discharged from the housing.
    Type: Grant
    Filed: May 3, 2016
    Date of Patent: July 16, 2019
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Young-Jin Kim, Ju-Hyun Kang, Young-Jae Kim, Byung Yul So, Yong-Gak Kim, In-Jung Baek, Na Yeong Byeon, Moo Gyo Seo, Hyeong Joon Seo, Seung Cheon Yu, Sang Woo Lee, Hyo Kyu Lee, Jin Ho Lim, Min-Gi Cho, Hyeong Kyu Cho, Jun Hwang, Do Yeon Kim, Hyun Ah Kim, Yong Ho Seo, Woo Seog Song, Hyun-Joo Song, Young Sun Shin, Joon-Ho Yoon, Bu Youn Lee, Jung Dae Lee, Chang Seon Lee, Min Gu Jeon, Hee Jae Jeong
  • Publication number: 20190162382
    Abstract: A lamp for a vehicle is provided. The lamp includes at least one light source which emits light, a first optical element disposed in front of the light source and including a first incident surface on which the light from the light source is incident and a first exit surface from which the light incident from the first incident surface exits, a second optical element disposed in front of the first optical element and including a second incident surface on which the light exiting from the first optical element is incident and a second exit surface from which the light incident on the second incident surface exits, and a light transmission portion disposed between the first and the second optical elements. The first and the second optical elements have a first refractive index, and the light transmission portion has a second refractive index different from the first refractive index.
    Type: Application
    Filed: October 15, 2018
    Publication date: May 30, 2019
    Inventors: Da Il Kang, Hyo Jin Han
  • Publication number: 20190133969
    Abstract: The present invention relates to a coenzyme Q10 solubilizing composition and a method for preparing the same. In the coenzyme Q10 solubilizing composition and the method for preparing the same according to the present invention, coenzyme Q10, which is a non-soluble drug, is encapsulated by a micelle containing glycyrrhizic acid or a salt of glycyrrhizic acid, bile acid, and unsaturated fatty acid, thereby improving encapsulation efficiency and improving the solubility of coenzyme Q10 in water. In addition, the mass-production of the composition can be easily achieved through sonication or a microfluidizer, the particle size of the composition encapsulating coenzyme Q10 can be controlled, and the natural substance-based formulation without using ethanol and an organic solvent are possible, so that it is expected that the composition of the present invention can be favorably utilized as a composition for pharmaceuticals, foods, and cosmetics, the composition having ensured stability and almost no toxicity.
    Type: Application
    Filed: April 19, 2017
    Publication date: May 9, 2019
    Inventors: Sang Jeon CHUNG, Ju Hwan KIM, Hyo Jin KANG
  • Patent number: 10038336
    Abstract: The present invention relates to a power duplication apparatus for an HVDC system and a control method therefor, and the power duplication apparatus for an HVDC system comprises: a first independent power generator receiving first input power so as to generate and output first power; a second independent power generator receiving second input power so as to generate and output the first power; a first power supplier selectively receiving the first power output, respectively, from the first independent power generator and the second independent power generator so as to convert the first power into second power having a smaller size than that of the first power and output the same; a second power supplier for selectively receiving the first power output, respectively, from the first independent power generator and the second independent power generator so as to convert the first power into the second power having a smaller size than that of the first power and output the same; a first HVDC controller for receiv
    Type: Grant
    Filed: December 26, 2014
    Date of Patent: July 31, 2018
    Assignee: HYOSUNG CORPORATION
    Inventors: Jae-Hoon Oh, Hyo-Jin Kang
  • Publication number: 20170371310
    Abstract: The present invention provides a method for operating dual controller which monitors the state of a dual controller to determine whether the dual controller is faulty and enables operation thereof with a controller in a normal state. An operation method of a dual controller according to the present invention dq-converts control command output values of first and second controllers to calculate rates of change in dq conversion values and dq-converts feedback input values, fed back to the first and second controllers, to calculate average rates of change in dq conversion values. When the average rates of change in the dq conversion values for the control command output values and the average rates of change in the dq conversion values for the feedback input values for the respective first and second controllers are identical, the corresponding controller is determined to be in a normal state, and to be in a faulty state otherwise.
    Type: Application
    Filed: December 29, 2015
    Publication date: December 28, 2017
    Inventors: Hyo-Jin KANG, Jae-Keun NO
  • Publication number: 20160329740
    Abstract: The present invention relates to a power duplication apparatus for an HVDC system and a control method therefor, and the power duplication apparatus for an HVDC system comprises: a first independent power generator receiving first input power so as to generate and output first power; a second independent power generator receiving second input power so as to generate and output the first power; a first power supplier selectively receiving the first power output, respectively, from the first independent power generator and the second independent power generator so as to convert the first power into second power having a smaller size than that of the first power and output the same; a second power supplier for selectively receiving the first power output, respectively, from the first independent power generator and the second independent power generator so as to convert the first power into the second power having a smaller size than that of the first power and output the same; a first HVDC controller for receiv
    Type: Application
    Filed: December 26, 2014
    Publication date: November 10, 2016
    Inventors: Jae-Hoon OH, Hyo-Jin KANG
  • Publication number: 20160166592
    Abstract: Disclosed herein are compounds, compositions and methods for the treatment of a disease or disorder related to activation of deacetylase enzymes. The compounds and methods are related to boronic acid derivatives of resveratrol. In some forms, the compound, compositions and methods relate to treatment of prostate cancer, colon cancer, or breast cancer, a cardiovascular disease, inflammation, obesity, diabetes, or a neurodegenerative disease.
    Type: Application
    Filed: July 3, 2014
    Publication date: June 16, 2016
    Inventors: Insoo Bae, Yong Weon Yi, Hyo Jin Kang, Hee Jeong Kim
  • Publication number: 20140242606
    Abstract: The present invention relates to a probe for iFRET and use thereof. Specifically, the present invention relates to a novel probe for iFRET, a method for preparing the probe for iFRET, a method for searching a target protein-specific binding site or a molecule having the binding site using the probe for iFRET, and a method for imaging the target protein using the probe for iFRET. The probe for iFRET according to the present invention utilizes an amino acid in a protein as a fluorescent donor, unlike the conventional FRET method. Therefore, only one fluorescent material is used, and its emission wavelength is distinct from the intrinsic fluorescence of the protein. Thus, high specificity and sensitivity are ensured, and the quantity, activity and mechanism of various proteins can be analyzed in an easy and accurate manner.
    Type: Application
    Filed: June 25, 2012
    Publication date: August 28, 2014
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Sang Jeon Chung, Ju Hwan Kim, Elena Ruchkina, Hyo Jin Kang
  • Publication number: 20140170769
    Abstract: A microscope apparatus for detecting or imaging a target protein using a probe for intrinsic fluorescence resonance energy transfer (iFRET) according to the present invention comprises: a light irradiation unit that irradiates a first light having a wavelength range for exciting an amino acid in the target protein and a second light having a wavelength range for exciting a fluorescent molecule of the probe for iFRET; an objective lens that allows the lights irradiated from the light irradiation unit to be incident onto a sample into which the probe for iFRET is introduced; and a recognition unit that detects a first light emitting signal generated from the probe for iFRET by irradiating the first light having a wavelength range for exciting an amino acid in the target protein onto the sample and a second light emitting signal generated from the probe for iFRET by irradiating the second light having a wavelength range for exciting a fluorescent molecule of the probe for iFRET onto the sample, wherein the probe
    Type: Application
    Filed: April 23, 2012
    Publication date: June 19, 2014
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Sang Jeon Chung, Hyo Jin Kang, Ju Hwan Kim
  • Patent number: 8642356
    Abstract: The present invention relates to a cascade enzyme-linked immunosorbent assay, more precisely a cascade enzyme-linked immunosorbent assay using magnetic microparticles (MMPs) immobilized with the target antigen specific primary antibody and silica nanoparticles (SPs) immobilized with a cascade reaction initiator and the antigen-specific secondary antibody. When the method of the present invention is applied in the detection of an antigen in biosamples, the detection sensitivity can be significantly increased.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: February 4, 2014
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Sang Jeon Chung, Young-mi Lee, Yu-Jin Jeong, Hyo Jin Kang, Bong Hyun Chung
  • Patent number: 8236509
    Abstract: The present invention relates to a method for preparing an protein monolayer using a peptide hybrid for protein immobilization, more precisely a peptide hybrid for protein immobilization which has improved solubility by introducing a PEG linker and a proper reaction group to the oligopeptide having specific affinity to selected types of proteins and is designed to provide enough space between solid substrates and proteins immobilized, whereby various solid substrates treated by the hybrid catch specific proteins effectively on. The peptide hybrid for protein immobilization of the present invention facilitates the control of orientation of an antibody on various solid surfaces and immobilization of various antibodies of different origins or having different isotypes with different affinity. Therefore, the surface treatment technique using the peptide hybrid of the invention can be effectively used for the production of various immunosensors and immune chips.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: August 7, 2012
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Sang Jeon Chung, Bong Hyun Chung, Yongwon Jung, Hyo Jin Kang, Jeong Min Lee
  • Publication number: 20100209945
    Abstract: The present invention relates to a method for preparing an protein monolayer using a peptide hybrid for protein immobilization, more precisely a peptide hybrid for protein immobilization which has improved solubility by introducing a PEG linker and a proper reaction group to the oligopeptide having specific affinity to selected types of proteins and is designed to provide enough space between solid substrates and proteins immobilized, whereby various solid substrates treated by the hybrid catch specific proteins effectively on. The peptide hybrid for protein immobilization of the present invention facilitates the control of orientation of an antibody on various solid surfaces and immobilization of various antibodies of different origins or having different isotypes with different affinity. Therefore, the surface treatment technique using the peptide hybrid of the invention can be effectively used for the production of various immunosensors and immune chips.
    Type: Application
    Filed: October 18, 2007
    Publication date: August 19, 2010
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Sang Jeon Chung, Bong Hyun Chung, Yongwon Jung, Hyo Jin Kang, Jeong Min Lee
  • Publication number: 20100196937
    Abstract: The present invention relates to a cascade enzyme-linked immunosorbent assay, more precisely a cascade enzyme-linked immunosorbent assay using magnetic microparticles (MMPs) immobilized with the target antigen specific primary antibody and silica nanoparticles (SPs) immobilized with a cascade reaction initiator and the antigen-specific secondary antibody. When the method of the present invention is applied in the detection of an antigen in biosamples, the detection sensitivity can be significantly increased.
    Type: Application
    Filed: May 30, 2008
    Publication date: August 5, 2010
    Inventors: Sang Jeon Chung, Young-mi Lee, Yu-Jin Jeong, Hyo Jin Kang, Bong Hyun Chung
  • Publication number: 20090155904
    Abstract: A inhibition method of target mRNA expression includes: (a) obtaining binding energy of a double combination section on a dsRNA sequence of all combination comprising complementary nucleotides to a random target mRNA; (b) dividing the binding energy into four sections on the dsRNA sequence of each combination to obtain a difference of the mean binding energy between each section and convert into a score of a relative combination energy pattern; (c) selecting siRNA whose inhibition efficiency to target mRNA is expected to be high by applying the converted score to the dsRNA sequence with other factors that affect the efficiency of siRNA; and (d) inhibiting target mRNA expression using the selected siRNA.
    Type: Application
    Filed: December 8, 2005
    Publication date: June 18, 2009
    Applicant: Bioneer Corporation
    Inventors: Young-Chul Choi, Han Oh Park, Sorim Choung, Young Joo Kim, Sang Soo Kim, Seong-min Park, Sang-Cheol Kim, Gyuman Yoon, Kyoung Oak Choi, Hyo Jin Kang